About Eskay Iodine Private Limited
Data last updated:
Eskay Iodine Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of L P Shah Holdings And Trades Llp. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 13 September 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2011PTC221911. Its GSTIN is 27AACCE8356L2Z5 (Maharashtra). The company holds 4 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹4 Cr. It is led by directors including Sunil Gulabchand Sharda and Samir Jayantilal Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at A – 3 Shivsagar Estate North Wing Dr. Annie Besant Road Worli, Mumbai, Maharashtra, India – 400018.
As per the financials filed for FY 2025, the company reported a revenue of ₹741.41 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹28.22 Cr (net margin 3.8%) and EBITDA of ₹52.45 Cr (EBITDA margin 7.1%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 35% over five years.
The company has about 184 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Eskay Iodine. As per MCA filings, the company has open charges of ₹350 Cr and satisfied charges of ₹10 Cr on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹19.95 Cr; the latest was in March 2016. Its 7 peer companies in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is Neogen Chemicals Limited with revenue of ₹781.57 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website eskayiodine.com.
Company details
Contact details
Eskay Iodine Private Limited's registered office is in Mumbai, Maharashtra. Its website is eskayiodine.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressA – 3 Shivsagar Estate North Wing Dr. Annie Besant Road Worli, Mumbai, Maharashtra, India – 400018
- IndustryChemicals and Materials, Specialty Chemicals
To see the full contact details of Eskay Iodine Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Eskay Iodine operates one associated brand: Eskay Iodine. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures iodine, bromine, and selenium derivatives for pharmaceutical and industrial uses. | eskayiodine.com |
Business activity
The main business activity of Eskay Iodine is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Eskay Iodine Private Limited, buy the company report.
Financials of Eskay Iodine Private Limited
FY 2024 filings availableEskay Iodine Private Limited reported revenue of ₹741.41 Cr (up 33% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 35% over five years, including 33% growth in the latest year. EBITDA rose 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹52.45 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹28.22 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.1% | ||||
| Net Profit Margin | 3.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eskay Iodine Private Limited, buy the company report.
Board of directors of Eskay Iodine Private Limited
Eskay Iodine has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Gulabchand Sharda | Director | 11 May 2021 | 5 Years 5 Months | Current |
| Samir Jayantilal Shah Also directs: Anuh Pharma Limited, Chaitanya Life Science Private Limited, Skites India LLP and 5 more | Director | 19 Oct 2011 | 15 Years 0 Months | Current |
| Ketan Lalit Shah Also directs: Anuh Pharma Limited, Chaitanya Life Science Private Limited, L P Shah Holdings and Trades LLP and 2 more | Director | 13 Sep 2011 | 15 Years 1 Months | Current |
| Bipin Nemchand Shah | Director | 19 Oct 2011 | 15 Years 0 Months | Current |
Peer comparison
Eskay Iodine Private Limited is compared with the 7 companies closest to it by revenue in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neogen Chemicals Limited | ₹781.57 Cr (FY 2025) | 12.0% | Thane, Maharashtra, India | |||
| Unitop Chemicals Private Limited | ₹774.29 Cr (FY 2025) | 18.0% | Mumbai, Maharashtra, India | |||
| Gramercy Trade Industries Private Limited | ₹767.72 Cr (FY 2025) | 1324.0% | Pune, Maharashtra, India | |||
| Eskay Iodine Private Limitedthis company | ₹741.41 Cr (FY 2025) | ₹28.22 Cr | 3.8% | 33.0% | 184 | Mumbai, Maharashtra, India |
| Gulbrandsen Technologies (India) Private Limited | ₹738.25 Cr (FY 2024) | 5.0% | Vadodara, Gujarat, India | |||
| Valiant Organics Limited | ₹727.4 Cr (FY 2025) | -1.0% | Mumbai, Maharashtra, India | |||
| Baerlocher India Additives Private Limited | ₹715.01 Cr (FY 2025) | 22.0% | Mumbai, Maharashtra, India | |||
| Gargi Huttenes Albertus Private Limited | ₹686.13 Cr (FY 2025) | 7.0% | Chembur Mumbai, Maharashtra, India |
To see the full peer comparison of Eskay Iodine Private Limited, buy the company report.
Auditor
Eskay Iodine Private Limited is audited by CHOKSHI & CHOKSHI LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CHOKSHI & CHOKSHI LLP | FY 2022 | 101872W/W100045 |
Shareholding
The shareholding of Eskay Iodine Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Eskay Iodine Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Feb 2013 | 10412405 | Hdfc Bank Limited | ₹50 Cr | Open | |
| 15 Jan 2013 | 10402829 | Hdfc Bank Limited | ₹300 Cr | Open | |
| 01 Mar 2018 | 100175738 | Hdfc Bank Limited | ₹5 Cr | Satisfied | |
| 08 Aug 2017 | 100156040 | Citi Bank N.A. | ₹5 Cr | Satisfied |
To see the full charge records of Eskay Iodine Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Eskay Iodine Private Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹19.95 Cr; the latest was in March 2016.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: L P Shah Holdings and Trades LLP , 2 individuals Seller: Plutonium Business Solution Private Limited |
| Sep 2014 | Secondary share transfer | Undisclosed | Buyer: Plutonium Business Solution Private Limited , an individual Seller: Plum PE Investments Limited, an individual |
| Mar 2012 | Funding round | ₹19.95 Cr | Investors: Plum PE Investments Limited, Plutonium Business Solution Private Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Eskay Iodine Private Limited has 1 court case on record: 1 filed by Eskay Iodine. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Bharuch, Gujarat | Criminal complaint | Filed by the company against individuals | Pending |
To see the full case history of Eskay Iodine Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Eskay Iodine Private Limited was last rated by Crisil on 16 Dec 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 16 Dec 2020 |
To see the full credit ratings and regulatory alerts of Eskay Iodine Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eskay Iodine Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Eskay Iodine has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Chaitanya Life Science Private Limited | U24230GJ2010PTC060902 |
To see the full group structure of Eskay Iodine Private Limited, buy the company report.
Employees & EPFO
Eskay Iodine Private Limited has a workforce of 184 employees on its EPFO records as of Mar 24, 2024, across 1 active EPFO establishment.
GST
Eskay Iodine has 4 GST registrations: 3 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCE8356L2Z5 | Maharashtra | Active | 11 Jul 2018 |
| 27AACCE8356L3Z4 | Maharashtra | Active | 01 Apr 2025 |
| 24AACCE8356L1ZC | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Eskay Iodine Private Limited, buy the company report.
Recent activity
Eskay Iodine Private Limited has 6 board changes on record since 2011: 4 appointments and 2 cessations. The latest: Lalit Popatlal Shah ceased to be Director on 10 Jan 2024.
5 earlier events are in the company report.
Frequently asked questions
Eskay Iodine is an active private limited company based in Mumbai, Maharashtra, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 13 September 2011 (15+ years old) and is registered under CIN U24100MH2011PTC221911.
Eskay Iodine has 4 current directors:
- Sunil Gulabchand Sharda - Director
- Samir Jayantilal Shah - Director
- Ketan Lalit Shah - Director
- Bipin Nemchand Shah - Director
The latest financial statements of Eskay Iodine on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Eskay Iodine is 27AACCE8356L2Z5, registered in Maharashtra. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 27AACCE8356L3Z4 (Maharashtra), 24AACCE8356L1ZC (Gujarat).
The CIN (Corporate Identification Number) of Eskay Iodine is U24100MH2011PTC221911. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eskay Iodine has 1 court case on record: 1 filed by the company. 1 is pending.
Eskay Iodine was incorporated on 13 September 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
Eskay Iodine has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹19.95 Cr; the latest was in March 2016.
The peers of Eskay Iodine by revenue are Neogen Chemicals Limited, Unitop Chemicals Private Limited, Gramercy Trade Industries Private Limited, Gulbrandsen Technologies (India) Private Limited, Valiant Organics Limited and 2 more, all in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Lalit Popatlal Shah ceased to be Director on 10 Jan 2024. Sunil Gulabchand Sharda ceased to be Additional Director on 30 Nov 2021. Sunil Gulabchand Sharda was appointed as Director on 11 May 2021. Eskay Iodine has 6 board changes on record in total.
Eskay Iodine can be reached through the website eskayiodine.com. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
